SCHEMBL9953767

SCHEMBL9953767

C=CCC1=CCC(OC)C=C1

nearest known ligand 0.32

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.31
TP53 P04637 1/20 0.31
CYP3A4 P08684 1/20 0.31
ALOX15 P16050 1/20 0.31
TSHR P16473 1/20 0.31
ALOX12 P18054 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14394189 0.83
SCHEMBL15593810 0.77
SCHEMBL13456923 0.77
SCHEMBL20880800 0.77
SCHEMBL16938662 0.75
SCHEMBL14823830 0.74 TAAR1 (0.32) CYP3A4TSHR
SCHEMBL14308023 0.73
SCHEMBL13772404 0.72
SCHEMBL16922190 0.70
SCHEMBL18408863 0.69 ALDH1A1 (0.35) ALDH1A1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3443988-A1 COMPOSITION AND USE OF COMPOSITION FOR COUNTERACTING AMMONIA MALODOR Firmenich SA (CH) 2019-02-20 EP claimed
US-9320821-B2 Method for counteracting ammonia malodor FIRMENICH SA (CH) 2016-04-26 US claimed
US-20130287721-A1 METHOD FOR COUNTERACTING AMMONIA MALODOR FIRMENICH SA (CH) 2013-10-31 US claimed
EP-2654809-A1 METHOD FOR COUNTERACTING AMMONIA MALODOR Firmenich SA (CH) 2013-10-30 EP claimed
WO-2012084916-A1 METHOD FOR COUNTERACTING AMMONIA MALODOR FIRMENICH SA (CH) 2012-06-28 WO claimed
EP-3697370-B1 HAIR COLORING COMPOSITION COMPRISING MICROCAPSULES FIRMENICH & CIE (CH) 2024-06-12 EP disclosed
EP-3443988-B1 COMPOSITION AND USE OF COMPOSITION FOR COUNTERACTING AMMONIA MALODOR FIRMENICH & CIE (CH) 2024-04-17 EP disclosed
CN-111417373-B Hair dyeing composition comprising microcapsules 弗门尼舍有限公司 2024-04-12 CN disclosed
US-20230338247-A1 WINTERGREEN FLAVOR COMPOSITIONS FREE OF METHYL SALICYLATE FIRMENICH SA (CH) 2023-10-26 US disclosed
CN-115697082-A Wintergreen flavor composition without methyl salicylate 弗门尼舍有限公司 2023-02-03 CN disclosed
US-11484480-B2 Hair coloring composition comprising microcapsules FIRMENICH SA (CH) 2022-11-01 US disclosed
US-11352314-B2 Fruity odorant FIRMENICH SA (CH) 2022-06-07 US disclosed
CN-111417373-A Hair dyeing composition comprising microcapsules 弗门尼舍有限公司 2020-07-14 CN disclosed
WO-2019145416-A1 HAIR COLORING COMPOSITION COMPRISING MICROCAPSULES FIRMENICH SA (CH) 2019-08-01 WO disclosed
EP-2654809-B1 METHOD FOR COUNTERACTING AMMONIA MALODOR FIRMENICH & CIE (CH) 2019-03-13 EP disclosed
EP-3443988-A1 COMPOSITION AND USE OF COMPOSITION FOR COUNTERACTING AMMONIA MALODOR Firmenich SA (CH) 2019-02-20 EP disclosed
US-9320821-B2 Method for counteracting ammonia malodor FIRMENICH SA (CH) 2016-04-26 US disclosed
US-20130287721-A1 METHOD FOR COUNTERACTING AMMONIA MALODOR FIRMENICH SA (CH) 2013-10-31 US disclosed
EP-2654809-A1 METHOD FOR COUNTERACTING AMMONIA MALODOR Firmenich SA (CH) 2013-10-30 EP disclosed
WO-2012084916-A1 METHOD FOR COUNTERACTING AMMONIA MALODOR FIRMENICH SA (CH) 2012-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11352314-B2 Fruity odorant C5, TAS1R3, TAS1R1 ALDH1A1 142/4885TP53 3672/4885CYP3A4 117/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.